This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: The University of Chicago. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Aslan Mansurov: Innovator in Medical Therapeutics
Introduction
Aslan Mansurov is a notable inventor based in Chicago, IL, who has made significant contributions to the field of medical therapeutics. With a focus on innovative methods for treating inflammatory and autoimmune conditions, he has developed groundbreaking compositions that aim to improve patient outcomes.
Latest Patents
Mansurov holds 2 patents that showcase his expertise and dedication to advancing medical science. His latest patents include "Methods and Compositions for Treating Inflammatory and Autoimmune Conditions with ECM-Affinity Peptides Linked to Anti-Inflammatory Agents" and "Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Cytokines." These patents address critical needs in the medical field by providing targeted therapies that limit systemic exposure and reduce side effects.
Career Highlights
Aslan Mansurov is affiliated with The University of Chicago, where he continues to engage in research and development of innovative therapeutic methods. His work is characterized by a commitment to enhancing the efficacy of treatments for complex medical conditions.
Collaborations
Mansurov collaborates with esteemed colleagues, including Jun Ishihara and Ako Ishihara, to further his research initiatives. These collaborations enhance the scope and impact of his work in the medical field.
Conclusion
Aslan Mansurov is a pioneering inventor whose contributions to medical therapeutics are shaping the future of treatment for inflammatory and autoimmune conditions. His innovative patents and collaborative efforts underscore his commitment to advancing healthcare solutions.